Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Pocenbrodib hydrochloride by Pathos AI for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
Pocenbrodib hydrochloride is under clinical development by Pathos AI and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC)....